BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 25565142)

  • 21. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
    Lejonklou MH; Barbu A; Stålberg P; Skogseid B
    Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
    Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
    PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
    Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
    Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
    PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3.
    Hu D; Su C; Jiang M; Shen Y; Shi A; Zhao F; Chen R; Shen Z; Bao J; Tang W
    Biochem Biophys Res Commun; 2016 Mar; 471(2):290-5. PubMed ID: 26850851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
    Shen HC; He M; Powell A; Adem A; Lorang D; Heller C; Grover AC; Ylaya K; Hewitt SM; Marx SJ; Spiegel AM; Libutti SK
    Cancer Res; 2009 Mar; 69(5):1858-66. PubMed ID: 19208834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
    Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
    Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
    Zhang J; Lin Z; Gao Y; Yao T
    J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.
    Chunharojrith P; Nakayama Y; Jiang X; Kery RE; Ma J; De La Hoz Ulloa CS; Zhang X; Zhou Y; Klibanski A
    Mol Cell Endocrinol; 2015 Nov; 416():27-35. PubMed ID: 26284494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
    Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
    Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
    Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of Long Noncoding RNA Meg3 Affects Insulin Synthesis and Secretion in Mouse Pancreatic Beta Cells.
    You L; Wang N; Yin D; Wang L; Jin F; Zhu Y; Yuan Q; De W
    J Cell Physiol; 2016 Apr; 231(4):852-62. PubMed ID: 26313443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
    Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mice With RIP-Cre-mediated Deletion of the Long Noncoding RNA
    Parekh VI; Sun H; Chen M; Weinstein LS; Agarwal SK
    J Endocr Soc; 2022 Oct; 6(11):bvac141. PubMed ID: 37283960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications.
    Liu IH; Ford JM; Kunz PL
    Cancer Treat Rev; 2016 Mar; 44():1-9. PubMed ID: 26924193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.